Preclinical Development

We perform cutting-edge preclinical studies of ophthalmology drugs and devices to support international submissions (EMEA and FDA).

Iris Pharma offers the partial or global performance of preclinical studies for our clients. We propose pharmacologic studies in animals to investigate the method of action and effects of a substance in the eye, as well as highly controlled Good Laboratory Practice (GLP) studies to determine the ocular safety, tolerance, pharmacokinetics, and toxicokinetics of test drugs and devices.

 

"As soon as we have a solution or drug to test in animal models, we are thinking about humans", Pierre-Paul Elena, CEO of Iris Pharma 

 

 KEY FIGURE: 2,600 ocular preclinical studies completed since 1989